Novo Nordisk A/S
DEEURNovo Nordisk A/S (US:NONOF) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 3. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
- Novo Nordisk A/S — NOVO-B · CO DK Número de registro desconocido
Sobre la Empresa
- Sitio Web
- novonordisk.com
- Sector
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede Central
- BAGSVAERD DENMARK, Denmark
- Consejero Delegado
- Maziar Mike Doustdar
- Empleados
- 66 700
- Acciones en Circulación
- 3.34 mil M
- Capital Flotante
- 3.17 mil M
- Capitalización Bursátil
- 150.93 mil M EUR
- Insiders
- 5.27%
- Inversores Institucionales
- 33.78%
- Industria (SIC)
- Pharmaceutical Preparations
- Forma Jurídica
- ZRPO
- ISIN
- DK0060534915
- LEI
- 549300DAQ1CVT6CXN342
- Ratio de Reparto
- 50.5%
- FCF
- 59.0 mil M DKK
- Pagos / FCF
- 88%
- Deuda
- 143 mil M DKK2.0 a. de FCF
- Racha de Dividendos
- 24 a.
- Beneficios, FCF y dividendos pagados — para los 12 meses hasta 31.12.2025 (el último informe de la compañía).
Descripción
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. The company has a collaboration with Anthropic accelerate the development of new medicines and advance AI-driven software development. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. It has a strategic collaboration with Orbis Medicines to discover and develop oral macrocycle therapeutics for cardiometabolic diseases. The company was formerly known as Novo Industri A/S and changed its name to Novo Nordisk A/S in April 1989. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Dividendos
Novo Nordisk A/S (NONOF) paga dividendos dos veces al año. Por año (12 meses hasta e incluyendo el último pago anunciado): 11.7 DKK por acción (pagos: 2). Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 15.02.2027. Historial de dividendos ininterrumpido: 24 años.
| Fecha Ex | Pago | Importe | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-08-17 | 2026-08-18 | 3.7500 DKK | 1.2/3.9 % | semestral | US:NONOF |
| 2026-03-30 | 2026-03-31 | 7.9500 DKK | 3.4/5.0 % | semestral | US:NONOF |
| 2025-08-18 | 2025-08-19 | 3.7500 DKK | 1.1/3.4 % | semestral | US:NONOF |
| 2025-03-31 | 2025-04-01 | 7.9000 DKK | 1.7/2.5 % | semestral | US:NONOF |
| 2024-08-16 | 2024-08-19 | 3.5000 DKK | 1.4/3.8 % | semestral | US:NONOF |
| 2024-03-22 | 2024-03-26 | 6.4000 DKK | 2.5/≈4.9 % | semestral | US:NONOF |
Principales Accionistas
| Titular | Participación | Acciones | Fecha del Informe |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.38% | 46.88 M | 2026-07-31 |
| EuroPacific Growth Fund-… | 1.07% | 36.2 M | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.92% | 31.13 M | 2026-06-30 |
| Capital World Growth & I… | 0.77% | 26.02 M | 2026-06-30 |
| iShares Trust-iShares Co… | 0.71% | 24.13 M | 2026-08-31 |
| Income Fund of America | 0.52% | 17.78 M | 2026-07-31 |
| Dodge & Cox Funds-Dodge… | 0.39% | 13.1 M | 2026-06-30 |
| Fidelity Concord Street… | 0.37% | 12.52 M | 2026-07-31 |
| iShares Trust-iShares MS… | 0.34% | 11.48 M | 2026-08-31 |
| Capital Income Builder | 0.3% | 10.32 M | 2026-07-31 |
| Cygnus Capital Advisors,… | 0% | 78 800 | 2026-06-30 |
| Generali Investments Cee… | 0% | 27 399 | 2026-06-30 |
| Pacer Advisors, Inc. | 0% | 24 410 | 2026-06-30 |
| Atlas Capital Advisors I… | 0% | 5 218 | 2026-06-30 |
| Novo Holdings | — | — | — |
| Novo Nordisk Foundation | — | — | — |
